mRNA vaccines encoding variant forms of Sm-TSP-2 confer protective immunity against Schistosoma mansoni
Athos Silva de Oliveira, Sevan Alwan, Philip T. LoVerde, Ramiz Shaheed, Pranav Mandyam, Rakesh Adhikari, Peter Hotez, Maria Elena Bottazzi, Jeroen Pollet · 2025
Read mRNA vaccines encoding variant forms of Sm-TSP-2 confer protective immunity against Schistosoma mansoni by Athos Silva de Oliveira, Sevan Alwan, Philip T. LoVerde, Ramiz Shaheed, Pranav Mandyam, Rakesh Adhikari, Peter Hotez, Maria Elena Bottazzi, Jeroen Pollet (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-12714763.txt.
Description
De Oliveira and co-authors test mRNA vaccine designs against a parasitic worm, in a 2025 study. Schistosoma mansoni causes schistosomiasis, a major tropical disease, and its surface protein Sm-TSP-2 is a leading vaccine target. The team built mRNA constructs for the full protein and for its outer loop in secreted, membrane-anchored, and internal forms. Mice were vaccinated and then assessed for antibodies, worm counts, and egg counts.
The secreted and membrane-anchored loop versions raised the strongest antibody responses. Both, plus the full-length design, cut adult worm and egg burdens clearly. The membrane-anchored loop did best, lowering worms and eggs by about two-thirds. Liver damage around eggs also shrank. Protection matched a protein vaccine with alum, a standard booster.
Catalog record
| CREATOR | Athos Silva de Oliveira, Sevan Alwan, Philip T. LoVerde, Ramiz Shaheed, Pranav Mandyam, Rakesh Adhikari, Peter Hotez, Maria Elena Bottazzi, Jeroen Pollet |
|---|---|
| YEAR | 2025 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 34 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |